XML 64 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2021
Income Tax Disclosure [Abstract]  
Schedule of Significant Components of the Company's Deferred Tax Asset

In respect of:

December 31,

December 31,

2021

2020

USD thousands

USD thousands

Net operating loss carry-forwards

33,396

4,874

Share-based compensation expense

1,147

57

Research and development costs

1,449

1,244

Other

38

25

Gross deferred tax assets

36,030

6,200

Less - Valuation allowance

(36,030

)

(6,200)

 

Net deferred tax assets

-

-

Schedule of Roll Forward of Valuation Allowance

E.Roll forward of valuation allowance

Balance at January 1, 2020

$

4,248

Currency transaction loss

583

Income tax expense

1,369

Balance at December 31, 2020

$

6,200

Currency transaction loss

2,425

Tax assets acquired through merger

24,535

Income tax expense

2,870

Balance at December 31, 2021

$

36,030

Schedule of Reconciliation of Theoretical Income Tax Expense to Actual Income Tax Expense

A reconciliation of the Company’s theoretical income tax expense to actual income tax expense is as follows:

December 31,

December 31,

2021

2020

USD thousands

USD thousands

Loss before income taxes

(12,478

)

(5,951

)

Statutory tax rate

23

%

23

%

Theoretical tax benefit

(2,870

)

(1,369

)

 

Losses and other items for which a valuation allowance was provided or benefit from loss carryforwards

2,870

1,369

 

Actual income tax expense

-

-